Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease
Bowel obstruction: Blockage in the intestines requiring immediate medical intervention
We compare drugs using two different numbers: Perfect Use (Completers): In the OASIS 4 study, people who took the pill perfectly for the whole year lost about 17% of their weight
For people who use one of the two new GLP-1s, semaglutide (Wegovy) or tirzepatide (Zepbound) to lose weight, the results can vary from person to person
The support and guidance Ive received have truly given me my life back
Krner, M., Stckli, M., Waser, B